戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 TLV-1-associated myelopathy/tropical spastic paraparesis.
2 hology of HTLV-1-associated/tropical spastic paraparesis.
3 TLV-1-associated myelopathy-tropical spastic paraparesis.
4 TLV-I-associated myelopathy/tropical spastic paraparesis.
5 ents with HTLV-II seropositivity and spastic paraparesis.
6 TLV-1-associated myelopathy/tropical spastic paraparesis.
7 TLV-1 associated-myelopathy/tropical spastic paraparesis.
8 n those who did not develop quadriparesis or paraparesis.
9 in debilitating leukodystrophies and spastic paraparesis.
10 TLV-1-associated myelopathy/tropical spastic paraparesis.
11 TLV-1-associated myelopathy/tropical spastic paraparesis.
12 TLV-I-associated myelopathy/tropical spastic paraparesis.
13 TLV-1-associated myelopathy/tropical spastic paraparesis.
14 TLV-I-associated myelopathy/tropical spastic paraparesis.
15 or neuron disorders characterized by spastic paraparesis.
16 ype I-associated myelopathy/tropical spastic paraparesis.
17 ype I-associated myelopathy/tropical spastic paraparesis.
18 sive gait ataxia with a superimposed spastic paraparesis.
19 ype I-associated myelopathy/tropical spastic paraparesis.
20 , with limb and gait ataxia and mild spastic paraparesis.
21 1 null mice in addition to prominent spastic paraparesis.
22 affected by Alzheimer's disease with spastic paraparesis.
23 TLV-I-associated myelopathy/tropical spastic paraparesis.
24 TLV-1-associated myelopathy/tropical spastic paraparesis.
25  HTLV-I-associated myopathy/tropical spastic paraparesis.
26 which is, in most cases, preceded by spastic paraparesis.
27 TLV-1-associated myelopathy/tropical spastic paraparesis?
28       Thirty-five patients had paraplegia or paraparesis (5.4%).
29 (20/30; 66.7%), spinal cord involvement with paraparesis (8/30; 26.7%), and optochiasmatic arachnoidi
30 ed, patients frequently present with spastic paraparesis, a thin corpus callosum, and cognitive impai
31 rus-1-associated myelopathy/tropical spastic paraparesis, A6 also recognizes a self peptide from the
32 ined independent association with paraplegia-paraparesis after multivariate analysis.
33 TLV-1-associated myelopathy/tropical spastic paraparesis after the initial infection.
34 tis, cervical myelopathy from syringomyelia, paraparesis, amenorrhea-galactorrhea, and other endocrin
35 TLV-1-associated myelopathy/tropical spastic paraparesis and adult T cell leukemia.
36 a similar combination of progressive spastic paraparesis and polyneuropathy, variably associated with
37                        A man in his 30s with paraparesis and urinary incontinence had a long-segment
38 motor CD (nine with hemiparesis and six with paraparesis) and 25 age- and gender-matched healthy volu
39 TLV-1-associated myelopathy/tropical spastic paraparesis, and HTLV-1-associated uveitis.
40 ive spasticity that led to gait alterations, paraparesis, and oromotor dysfunction.
41 phalomyeloradiculitis had a moderate flaccid paraparesis, and the patient with subacute meningomyelor
42 ho developed acute onset of quadriparesis or paraparesis associated with abnormal brain and/or spine
43 TLV-I-associated myelopathy/tropical spastic paraparesis), by reducing the proviral load of HTLV-I; h
44 TLV-I-associated myelopathy/tropical spastic paraparesis, characterized pathologically by inflammatio
45 dhood disease onset, ID, progressive spastic paraparesis, dysarthria, dysmorphisms, and white matter
46 TLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) and adult T cell leukemia/lymphoma
47 TLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP) and chronic Lyme neuroborreliosis.
48 LV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) and multiple sclerosis (MS).
49 LV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) and multiple sclerosis (MS).
50 LV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) are known to be caused by HTLV-I i
51 ype I-associated myelopathy/tropical spastic paraparesis (HAM/TSP) based on newly developed molecular
52 LV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) exhibit reduced Foxp3 expression a
53 LV-I-associated) myelopathy/tropical spastic paraparesis (HAM/TSP) has been shown to be a major reser
54 LV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) is a chronic neurological conditio
55 LV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) is a chronic, progressive neurolog
56 LV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) is a neurological disease that res
57 LV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) is a progressive inflammatory myel
58 LV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) is an immune-mediated inflammatory
59 LV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) is an inflammatory neurologic dise
60 LV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) is an inflammatory neurologic dise
61 LV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) is associated with immunoreactivit
62 TLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP) is poorly understood.
63  HTLV-associated myelopathy/tropical spastic paraparesis (HAM/TSP) or develop a plethora of other inf
64 LV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) proliferate spontaneously in vitro
65 TLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP) results in a decrease in FOXP3 mRN
66 TLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP), a chronic inflammatory disease of
67 LV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP), a disease that can be indistingui
68 TLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP), a progressive neurodegenerative d
69 TLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP), an immune-mediated disorder of th
70 TLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP), mono- or oligoclonal expansions w
71 TLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP), observed in up to 5% of infected
72 TLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP), or adult T cell leukemia/lymphoma
73 ted myelopathy, also called tropical spastic paraparesis (HAM/TSP).
74 TLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
75 -I-associated myelopathy or tropical spastic paraparesis (HAM/TSP).
76 TLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
77 TLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
78 TLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
79 TLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
80 TLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
81 LV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
82 TLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
83 TLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
84 TLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
85 rus I-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
86 TLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
87 TLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
88 TLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
89 TLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
90 TLV-I-associated myelopathy/tropical spastic paraparesis [HAM/TSP]) is suggested to be an immunopatho
91 ype I-associated myelopathy/tropical spastic paraparesis has been reported and is thought to be relat
92      We studied a case of Hereditary Spastic Paraparesis (HSP) in a single inbred Palestinian family.
93 found in ex vivo samples of tropical spastic paraparesis-HTLV-1-associated myelopathy patients contai
94 ion of different alleles in tropical spastic paraparesis-HTLV-associated myelopathy and ATLL or healt
95  neurodegenerative disorder tropical spastic paraparesis/HTLV-1-associated myelopathy (TSP/HAM).
96 -cell leukemia/lymphoma and tropical spastic paraparesis/HTLV-1-associated myelopathy in about 5% of
97 -cell leukemia/lymphoma and tropical spastic paraparesis/HTLV-1-associated myelopathy, among other di
98 eukemia/lymphoma as well as tropical spastic paraparesis/HTLV-1-associated myelopathy.
99 r adult T-cell leukemia and tropical spastic paraparesis/HTLV-I-associated myelopathy.
100 d the neurological disorder tropical spastic paraparesis/HTLV-I-associated myelopathy.
101 iency is a rare cause of complicated spastic paraparesis in adults, it should be considered in select
102 tterns of proprioceptive ataxia and evolving paraparesis in EVR versus irreversible paraplegia in OR.
103 d myelopathy (also known as tropical spastic paraparesis), infective dermatitis of children and uveit
104 ype I-associated myelopathy/tropical spastic paraparesis is a chronic progressive inflammatory neurol
105 TLV-1) -associated myelopathy/tropic spastic paraparesis is a demyelinating inflammatory neurologic d
106                                      Spastic paraparesis is thought to be an occasional manifestation
107 ed novel clinical presentations with spastic paraparesis mimicking hereditary spastic paraplegia, and
108 s adult T-cell leukemia and tropical spastic paraparesis/myelopathy.
109 parkinsonism (n = 1), and hereditary spastic paraparesis (n = 1).
110                     Three cases of transient paraparesis occurred (all in patients requiring mesenter
111            SCI occurred in 45 patients (8%), paraparesis occurring in 23 (4%) and paraplegia in 22 pa
112 TLV-1-associated myelopathy/tropical spastic paraparesis), ongoing infectious spread during chronic i
113 l manifestations, including tropical spastic paraparesis or HTLV-1-associated myelopathy (TSP/HAM).
114 stoperative spinal cord injury manifested as paraparesis or paraplegia of 9.9% (9/91).
115 use spinal cord (SC) injury that can lead to paraparesis or paraplegia.
116  cord injury (SCI) was graded as ambulatory (paraparesis) or nonambulatory (paraplegia).
117                                              Paraparesis-paraplegia occurred in 7%, an incidence sign
118 cated form of adult-onset hereditary spastic paraparesis partially responsive to betaine therapy.
119  HTLV-1-associated myelopathy/tropic spastic paraparesis patients carried a significant number (up to
120 ype I-associated myelopathy/tropical spastic paraparesis patients using real-time quantitative polyme
121      Instead, children with quadriparesis or paraparesis post-CART therapy had lower levels of proinf
122 rus I-associated myelopathy/tropical spastic paraparesis, rheumatoid arthritis, multiple sclerosis an
123 TLV-1-associated myelopathy/tropical spastic paraparesis risk.
124   Neurosensory hearing loss, ataxia, spastic paraparesis, sphincter dysfunction, somatosensory distur
125 TLV-I-associated myelopathy/tropical spastic paraparesis suggest that HTLV-I may infect other cell ty
126 TLV-1-associated myelopathy/tropical spastic paraparesis than in 29 asymptomatic carriers (80% vs 20%
127 associated myelopathy (HAM)/tropical spastic paraparesis (TSP)] and subcortical ischaemic damage.
128 TLV-1-associated myelopathy/tropical spastic paraparesis was associated with a lower expression (comp
129 TLV-1-associated myelopathy/tropical spastic paraparesis was associated with significantly increased
130                                              Paraparesis was noted at the initial clinical examinatio
131                                              Paraparesis was noted on the initial clinical examinatio
132 raplegia (HSP) underlies progressive spastic paraparesis with accompanying ventriculomegaly and thinn
133 rodegenerative subtype of lower limb spastic paraparesis with additional diffuse skin and hair dyspig

 
Page Top